Trials / Conditions / Substance Dependence

Substance Dependence

53 registered clinical trials studyying Substance Dependence — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Neuroimaging of Adolescent Cannabis Use Treatment NCT07340554	Indiana University	N/A
Recruiting	Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees NCT06899308	Jacobs University Bremen gGmbH	—
Recruiting	A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs NCT05679284	Tampere University Hospital	—
Unknown	Correlation of Genetic Variations With Clinical Response in Substance Use Disorder NCT05833399	Alexandria University	—
Active Not Recruiting	Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD) NCT04768920	University of Michigan	N/A
Active Not Recruiting	Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients NCT05410561	University of Michigan	N/A
Unknown	Brain Mechanism and Intervention of Executive-control Dysfunction Among Substance Dependents NCT05312359	Shanghai Mental Health Center	N/A
Active Not Recruiting	Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders NCT05348317	VA Office of Research and Development	N/A
Recruiting	Pre-exposure Prophylaxis (PrEP) for Health NCT04430257	Brown University	N/A
Withdrawn	Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone NCT03762798	The Cleveland Clinic	N/A
Completed	Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Tr NCT03767907	Centre for Addiction and Mental Health	N/A
Completed	Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction NCT03000699	Centre for Addiction and Mental Health	N/A
Completed	Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 NCT03048552	New York State Psychiatric Institute	N/A
Completed	Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence NCT02461732	The University of Texas Health Science Center, Houston	N/A
Withdrawn	Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI) NCT01515917	Deborah Yurgelun-Todd	N/A
Unknown	Distress Tolerance Treatment for Substance Users NCT01741415	University of South Florida	Phase 2
Completed	Evaluation of Impulsivity on Cocaine and Crack Addicts NCT01550887	Federal University of São Paulo	N/A
Completed	Memory Reconsolidation Blockade for Treating Drug Addiction NCT01634347	Douglas Mental Health University Institute	Phase 2
Withdrawn	Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole NCT01155544	Northwell Health	Phase 4
Completed	Intervention Targeting Substance Using Older Adults With HIV NCT01305629	Hunter College of City University of New York	N/A
Active Not Recruiting	Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care NCT01621711	Kaiser Permanente	N/A
Completed	fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults NCT01320748	Inova Health Care Services	N/A
Unknown	Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers NCT01314378	Massachusetts General Hospital	N/A
Completed	Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment NCT01410110	Yale University	Phase 2
Completed	Efficacy Trial of Warrior Check-Up NCT01128140	University of Washington	Phase 2
Completed	A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence NCT01011907	University of California, San Francisco	N/A
Unknown	A Dose Ranging Study of Modafinil for Methamphetamine Dependence NCT00630097	California Pacific Medical Center Research Institute	Phase 2
Completed	GSK618334 Repeat Dose Study NCT01036061	GlaxoSmithKline	Phase 1
Withdrawn	Effects of GSK598809 on Brain Activation in Abstinent Alcoholics NCT00908206	GlaxoSmithKline	Phase 1
Completed	Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission NCT00657397	French National Agency for Research on AIDS and Viral Hepatitis	Phase 3
Completed	Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement NCT01039454	GlaxoSmithKline	Phase 1
Completed	An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as NCT00814957	GlaxoSmithKline	Phase 1
Withdrawn	Relapse Prevention Study in Newly Abstinent Smokers NCT00793468	GlaxoSmithKline	Phase 2
Completed	EtOH Interaction Study NCT00887367	GlaxoSmithKline	Phase 1
Completed	A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. NCT00728897	GlaxoSmithKline	Phase 1
Completed	A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers NCT00728052	GlaxoSmithKline	Phase 1
Unknown	Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction NCT00609089	University of Cincinnati	Phase 1 / Phase 2
Completed	A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward NCT00605241	GlaxoSmithKline	Phase 1
Completed	A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) NCT00604188	Merck Sharp & Dohme LLC	Phase 4
Completed	Motivational Therapy for Substance Users With Depression NCT01189799	University of California, Los Angeles	N/A
Completed	To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334 NCT00513279	GlaxoSmithKline	Phase 1
Completed	A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809 NCT00437840	GlaxoSmithKline	Phase 1
Completed	Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of NCT00437632	GlaxoSmithKline	Phase 1
Completed	Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment NCT00288886	US Department of Veterans Affairs	Phase 2
Completed	Group Therapy for Women Prisoners With Comorbid Substance Use and Depression NCT00606996	Brown University	N/A
Completed	Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation NCT00484692	Medical University Innsbruck	Phase 4
Completed	Stress, Distress Intolerance, and Drug Dependence NCT00430482	Boston University Charles River Campus	N/A
Completed	Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients NCT00295139	University of Maryland, Baltimore	N/A
Completed	Depakote ER Therapy for Mania Comorbid With Substance Abuse NCT00208195	Creighton University	Phase 4
Completed	Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia NCT00208143	Creighton University	Phase 4
Completed	Modifying Group Therapy for Bipolar Substance Abusers - 1 NCT00227838	National Institute on Drug Abuse (NIDA)	N/A
Completed	Adolescent Outpatient and Continuing Care Study NCT01381133	Chestnut Health Systems	Phase 3
Completed	Improving Substance Abuse Treatment Aftercare Adherence and Outcome NCT00057187	US Department of Veterans Affairs	N/A